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a b s t r a c t
Most patients with severe complications from COVID-19 have underlying conditions such
as obesity, diabetes, and hypertension. In parallel, there is growing evidence for a link
between periodontitis and non-oral systemic diseases. The oral cavity is also a reservoir for
respiratory pathogens, and patients with periodontal disease are more likely to develop
hospital-acquired pneumonia than healthy individuals. We therefore hypothesize that
improving oral health could decrease the severity of COVID-19 symptoms and reduce the
associated morbidity.
The new coronavirus SARS-CoV-2 was first detected in late
2019 and has quickly developed into a global pandemic [1]. Age
is one of the highest risk factors for developing severe symp-
toms of COVID-19, the disease caused by infection with
SARS-CoV-2 [2]. Thus, individuals over the age of 65 and those
living in long-term care facilities are especially vulnerable to
morbidity and mortality due to infection with SARS-CoV-2.
However, persons with chronic lung disease, moderate to
severe asthma, severe obesity, diabetes, chronic kidney dis-
ease, and liver disease are also at high risk for severe COVID-
19 symptoms. A recent study lists hypertension, obesity, and
diabetes as the three major underlying conditions with the
most unfavorable outcomes in COVID-19 patients requiring
hospitalization [3].
While COVID-19 can affect multiple organs in the body,
including the kidneys and liver [4,5], the main cause of
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mortality is due to the ability of SARS-CoV-2 to infect the
respiratory tract, leading to severe pneumonia. Patients with
COVID-19 display symptoms of fever, cough, dyspnea, and
other complications associatedwith acute respiratory distress
syndrome [6e8].
A salient feature of COVID-19 is its ability to trigger an
excessive immune reaction in the host, termed a ‘cytokine
storm’, which causes extensive tissue damage, particularly in
the connective tissue of the lungs [9]. The lung pathology of
patients who die from COVID-19 pneumonia includes edema,
focal reactive hyperplasia of pneumocytes with patchy inflam-
matory cellular infiltration, and multinucleated giant cells [10].
Oral health and non-oral systemic diseases
Over the past few years, it has been clear that oral health has a
large impact on general health. Several studies suggest that
cytokines or microbial products released systemically in
response to oral infection causes inflammation in distant or-
gans, which enhances development of systemic diseases such
as Alzheimer's disease, diabetes, atherosclerotic heart disease
and cerebrovascular disease [11e14]. Research has also shown
that poor oral health can increase complications of systemic
diseases like diabetes, chronic kidney disease and liver dis-
ease [11,15,16]. Conversely, obesity predisposes individuals to
oral diseases, especially gingivitis and periodontitis [17].
Furthermore, the oral cavity is a significant reservoir for
respiratory pathogens, including Chlamydia pneumoniae; and
patients with periodontal disease are more likely to develop
hospital-acquired pneumonia as a complication [18e20].
Severalmechanismsmay explain the ability of oral pathogens
to exacerbate lung infection, including aspiration of oral
pathogens into the lower respiratory tract, especially in high-
risk individuals; modification of mucosal surfaces along the
respiratory tract by salivary enzymes, which thereby facilitate
colonization by pathogens; and secretion of pro-inflammatory
cytokines during periodontitis, which can promote adhesion
to lung epithelium and lung colonization by respiratory
pathogens [21,22]. Improving oral hygiene may thus reduce
oropharyngeal colonization and the risk of respiratory
complications.
It has also been shown that improved oral hygiene and
frequent professional oral health care reduces the progression
or occurrence of respiratory diseases, particularly in the
elderly population and those in intensive care units [23].
This population is also most at risk for developing serious
complications related to COVID-19 [24,25].
Concluding statement
Older adults and people of any age who have serious medical
conditions such as chronic lung disease, diabetes, heart con-
ditions or chronic kidney disease are at high risk for devel-
oping severe illness due to SARS-CoV-2 infection. At the same
time, poor oral health increases the risk of developing the
same medical conditions. Therefore, improving oral health in
people of any age, by reducing their risk of developing non-
oral systemic diseases, may reduce the morbidity of COVID-
19 [Fig. 1]. Although the association between oral health and
severity of COVID-19 symptoms appears logical, more
research is needed to demonstrate the association
empirically.
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